Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01484041
Title Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Georgetown University|Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.